Overview
- The Albemarle County site at Rivanna Futures raises the budget by $500 million and will add manufacturing for ADC cancer medicines plus drug substance for oral GLP-1, baxdrostat, oral PCSK9 and combination therapies.
- AstraZeneca projects 600 permanent skilled roles in Virginia and about 3,000 construction jobs, totaling roughly 3,600 positions linked to the project.
- Work starts immediately with operations targeted in four to five years, using AI, automation and data analytics to optimize production.
- CMS Administrator Dr. Mehmet Oz attended the groundbreaking, underscoring the administration’s push to onshore medicine manufacturing.
- Reuters reports the investment follows tariff threats and other pressure on drugmakers, while analysts expect limited impact on overall prices and revenues.